perfusion of human placenta as a model of …...this powerpoint 2007 template produces a 36”x56”...

1
RESEARCH POSTER PRESENTATION DESIGN © 2011 www.PosterPresentations.com aa PERFUSION OF HUMAN PLACENTA AS A MODEL OF VASCULAR RESEARCH Pregnancy is the unique, short reproductive event with far reaching consequences for the individual, family and society. The placenta is the primary fetal organ of respiration, metabolism, nutrition and excretion. The early detection of placental dysfunction is critical for the fetal and maternal survival. Additionally the placenta is a highly vascular organ and has been used as a model for brain research and vascular responses. The structure and function of the placenta differs between male and female fetuses, which makes it a perfect model to study gender- dependent vascular responses. There are indeed obvious gender differences in vascular responsiveness and vascular metabolism, which has been identified in other vascular beds. The technique of placental perfusion in vitro provides a unique opportunity to evaluate the physiological responses to the vascular active substances and estimate the feto-maternal drug transfer. Abstract Maira Carrillo 1 , James Maher 1 , Gary Ventolini 1 , Ailena Mulkey 2 , Moss Hampton 1 and Natalia Schlabritz-Loutsevitch 1* 1 Dept. of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, Odessa 2 Clinical Research Institute, Odessa, TX *[email protected] The objective is to establish the model of perfusion of human placenta in-vitro and to record indirectly placental vessel contractility. Objectives After obtaining the informed consent, placenta was received after non- complicated cesarean section delivery, the fetal artery was immediately cannulated, followed by the cannulation of fetal vein (Figure1 A). The cannulation and flushing re-established the circulation in one of the intact cotyledons (Figure 1 B) at which time it is placed into the perfusion chamber (Figure 1 B). The re-established circulation is open circle fetal circulation (Figure 2). A basal fetal arterial hydrostatic pressure (FAHP) was recorded (Figure 3). After baseline is established, 3M KCl is added to induce vasoconstriction pressure is recorded using Lab Chart software (ADInstruments,U.S, Colorado Springs, Colorado). In addition to recording FAHP we also measure and record: temperature, pH, oxygen tension using Lab Chart. We also used the FLIR1 infrared technology to examine temperature of the sample which also provides indication that the placenta is still metabolically active. Materials and Methods The mean FAHP was 35.3±5 mmHg, mean weight of the cotyledons was 44.0±4 g. The temperature in the perfused cotyledon was constant throughout the experiment. Results Conclusions We were able to establish placental perfusion in vitro in our laboratory, the only placental perfusion lab in West Texas. Our data is in line with those published by Dr. Brownbill. We were able to establish a baseline FAHP and subsequently induce vasoconstriction using 3M KCl. Induction of vasoconstriction shows that the placenta is viable and metabolically active. Placenta perfusion is an excellent tool for the study fetal gender specific responses. Acknowledgements This study was supported by the funds of the Department of Obstetrics and Gynecology TTUHSC at the PB and regional Dean start-up funds to NSL. We acknowledge help of the Clinical Research institute in IRB preparation, patients’ management and consents. The critical advise and help of Dr. Paul Brownbill (University of Manchester, UK) is highly appreciated. We are deeply thankful medical staff and patients of MCH for their incredible support and understanding of this study. Figure 2. Perfusion system. Orange arrows show fetal and maternal reservoirs. Blue arrows show fetal and maternal peristaltic pumps. Green arrow heated water bath. Turquoise arrow perfusion chamber. Pink arrow syringe pump. Yellow arrow: tank for gassing maternal and fetal perfusate. Figure 3. Pressure recording of FAHP at baseline measurement and induction of vasoconstriction using 3M KCl. 0 10 20 30 40 50 60 20 30 40 50 60 70 80 Basal fetal arterial hydrostatic pressure (mmHg) Perfused cotyledon wet weight (g) Figure 4. Graphs showing Cotyledon weight vs FAHP ( Fetal arterial hydrostatic pressure) A) Data collected from our laboratory.B) Data collected from Laboratory of Dr. Brownbill (University of Manchester, UK) Table 1. Patient, fetal and placental information. Patient Gestational age (weeks) Maternal age (yrs) BMI fetal sex Newborn’s weight (g) Cotyledon Wt. (g) Fetal Pressure (mmHg) 1 39 25 28.21 female 3900 68.73 6.64 2 39 24 30.01 female 2830 30.4 19.46 3 29 34 25.31 male 3580 45.61 36.28 4 39 25 31.88 female 3330 63.2 38.67 5 39 23 24.20 female 2960 27.96 51.35 6 39 32 36.29 male 3480 43.2 33.23 7 39 24 25.76 male 3680 36.94 42.62 8 39 27 28.54 male 3330 35.6 53.78 9 39 23 36.15 male 3740 45.34 - Mean±SEM 38 26 29.60±1 3386.25±112 43.96±13 35.25±5 KCl Figure 1. Cannulation of vessels and corresponding cotyledon. A and C) Chorionic plate (A) where vessels are cannulated (C) (blue and orange arrow) B and D) Decidual surface (B) (maternal side) after isolation of placental lobule and cotyledon perfusion (D). Orange arrows point to temperature sensor. Turquiose arrow shows oxygen sensor E and F) temperature map of the maternal side of placenta in the perfusion chamber just prior to (E) and after (F) perfusion. G) Doppler image of perfused placental cotyledon in vitro, yellow arrow shows perfusate flowing through a vessel. Time (seconds) Baseline A C B D E F G B A

Upload: others

Post on 04-Jun-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PERFUSION OF HUMAN PLACENTA AS A MODEL OF …...This PowerPoint 2007 template produces a 36”x56” professional poster. It will save you valuable time placing titles, subtitles,

RESEARCH POSTER PRESENTATION DESIGN © 2011

www.PosterPresentations.com

QUICK DESIGN GUIDE (--THIS SECTION DOES NOT PRINT--)

This PowerPoint 2007 template produces a 36”x56”

professional poster. It will save you valuable time

placing titles, subtitles, text, and graphics.

Use it to create your presentation. Then send it to

PosterPresentations.com for premium quality, same

day affordable printing.

We provide a series of online tutorials that will guide

you through the poster design process and answer

your poster production questions.

View our online tutorials at:

http://bit.ly/Poster_creation_help

(copy and paste the link into your web browser).

For assistance and to order your printed poster call

PosterPresentations.com at 1.866.649.3004

Object Placeholders

Use the placeholders provided below to add new

elements to your poster: Drag a placeholder onto the

poster area, size it, and click it to edit.

Section Header placeholder

Use section headers to separate topics or concepts

within your presentation.

Text placeholder

Move this preformatted text placeholder to the poster

to add a new body of text.

Picture placeholder

Move this graphic placeholder onto your poster, size it

first, and then click it to add a picture to the poster.

QUICK TIPS (--THIS SECTION DOES NOT PRINT--)

This PowerPoint template requires basic PowerPoint (version 2007 or newer) skills. Below is a list of commonly asked questions specific to this template. If you are using an older version of PowerPoint some template features may not work properly.

Using the template Verifying the quality of your graphics Go to the VIEW menu and click on ZOOM to set your preferred magnification. This template is at 100% the size of the final poster. All text and graphics will be printed at 100% their size. To see what your poster will look like when printed, set the zoom to 100% and evaluate the quality of all your graphics before you submit your poster for printing. Using the placeholders To add text to this template click inside a placeholder and type in or paste your text. To move a placeholder, click on it once (to select it), place your cursor on its frame and your cursor will change to this symbol: Then, click once and drag it to its new location where you can resize it as needed. Additional placeholders can be found on the left side of this template. Modifying the layout This template has four different column layouts. Right-click your mouse on the background and click on “Layout” to see the layout options. The columns in the provided layouts are fixed and cannot be moved but advanced users can modify any layout by going to VIEW and then SLIDE MASTER. Importing text and graphics from external sources TEXT: Paste or type your text into a pre-existing placeholder or drag in a new placeholder from the left side of the template. Move it anywhere as needed. PHOTOS: Drag in a picture placeholder, size it first, click in it and insert a photo from the menu. TABLES: You can copy and paste a table from an external document onto this poster template. To make the text fit better in the cells of an imported table, right-click on the table, click FORMAT SHAPE then click on TEXT BOX and change the INTERNAL MARGIN values to 0.25

Modifying the color scheme

To change the color scheme of this template go to the

“Design” menu and click on “Colors”. You can choose

from the provide color combinations or you can

create your own.

© 2011 PosterPresentations.com 2117 Fourth Street , Unit C Berkeley CA 94710 [email protected]

Student discounts are available on our Facebook page.

Go to PosterPresentations.com and click on the FB icon.

aa

PERFUSION OF HUMAN PLACENTA AS A MODEL OF VASCULAR RESEARCH

Pregnancy is the unique, short reproductive event with far reaching

consequences for the individual, family and society. The placenta is the

primary fetal organ of respiration, metabolism, nutrition and

excretion. The early detection of placental dysfunction is critical for

the fetal and maternal survival. Additionally the placenta is a highly

vascular organ and has been used as a model for brain research and

vascular responses.

The structure and function of the placenta differs between male and

female fetuses, which makes it a perfect model to study gender-

dependent vascular responses. There are indeed obvious gender

differences in vascular responsiveness and vascular metabolism, which

has been identified in other vascular beds. The technique of placental

perfusion in vitro provides a unique opportunity to evaluate the

physiological responses to the vascular active substances and estimate

the feto-maternal drug transfer.

Abstract

Maira Carrillo1, James Maher1, Gary Ventolini1, Ailena Mulkey2, Moss Hampton1

and Natalia Schlabritz-Loutsevitch1*

1Dept. of Obstetrics and Gynecology, Texas Tech University Health Sciences Center, Odessa

2Clinical Research Institute, Odessa, TX

*[email protected]

The objective is to establish the model of perfusion of human placenta

in-vitro and to record indirectly placental vessel contractility.

Objectives

After obtaining the informed consent, placenta was received after non-

complicated cesarean section delivery, the fetal artery was

immediately cannulated, followed by the cannulation of fetal vein

(Figure1 A). The cannulation and flushing re-established the circulation

in one of the intact cotyledons (Figure 1 B) at which time it is placed

into the perfusion chamber (Figure 1 B). The re-established circulation

is open circle fetal circulation (Figure 2). A basal fetal arterial

hydrostatic pressure (FAHP) was recorded (Figure 3). After baseline is

established, 3M KCl is added to induce vasoconstriction pressure is

recorded using Lab Chart software (ADInstruments,U.S, Colorado

Springs, Colorado). In addition to recording FAHP we also measure and

record: temperature, pH, oxygen tension using Lab Chart. We also used

the FLIR1 infrared technology to examine temperature of the sample

which also provides indication that the placenta is still metabolically

active.

Materials and Methods

The mean FAHP was 35.3±5 mmHg, mean weight of the cotyledons was

44.0±4 g. The temperature in the perfused cotyledon was constant

throughout the experiment.

Results

Conclusions

• We were able to establish placental perfusion in vitro in our

laboratory, the only placental perfusion lab in West Texas.

• Our data is in line with those published by Dr. Brownbill.

• We were able to establish a baseline FAHP and subsequently induce

vasoconstriction using 3M KCl. Induction of vasoconstriction shows

that the placenta is viable and metabolically active.

• Placenta perfusion is an excellent tool for the study fetal gender

specific responses.

Acknowledgements

• This study was supported by the funds of the Department of

Obstetrics and Gynecology TTUHSC at the PB and regional Dean

start-up funds to NSL.

• We acknowledge help of the Clinical Research institute in IRB

preparation, patients’ management and consents.

• The critical advise and help of Dr. Paul Brownbill (University of

Manchester, UK) is highly appreciated.

• We are deeply thankful medical staff and patients of MCH for their

incredible support and understanding of this study.

Patient Gestational Age (weeks) Race

Maternal age (yrs ) BMI feta l sex

Feta l wt. (g)

Cotyledon Wt. (g)

Feta l Pressure (mmHg)

1 39 Hispanic 25 28.21 female 3900 68.73 6.64

2 39 Hispanic 24 30.01 female 2830 30.4 19.46

3 29 Hispanic 34 25.31 male 3580 45.61 36.28

4 39 Hispanic 25 31.88 female 3330 63.2 38.67

39 Black 23 24.20 female 2960 27.96 51.35

1 39 Hispanic 32 36.29 male 3480 43.2 33.23

2 39 Hispanic 24 25.76 male 3680 36.94 42.62

3 39 Hispanic 27 28.54 male 3330 35.6 53.78

4 39 White 23 36.15 male 3740 45.34 -

Figure 2. Perfusion system. Orange arrows show fetal and maternal reservoirs. Blue arrows show

fetal and maternal peristaltic pumps. Green arrow heated water bath. Turquoise arrow perfusion

chamber. Pink arrow syringe pump. Yellow arrow: tank for gassing maternal and fetal perfusate.

Figure 3. Pressure recording of FAHP at baseline measurement and induction of

vasoconstriction using 3M KCl.

0

10

20

30

40

50

60

20 30 40 50 60 70 80

Basa

l fe

tal art

eri

al

hydro

stati

c

pre

ssure

(m

mH

g)

Perfused cotyledon wet weight (g)

Figure 4. Graphs showing Cotyledon weight vs FAHP ( Fetal arterial hydrostatic pressure)

A) Data collected from our laboratory.B) Data collected from Laboratory of Dr. Brownbill (University of

Manchester, UK)

Table 1. Patient, fetal and placental information.

Patient

Gestational

age

(weeks)

Maternal

age (yrs) BMI fetal sex

Newborn’s weight

(g)

Cotyledon

Wt. (g)

Fetal

Pressure

(mmHg)

1 39 25 28.21 female 3900 68.73 6.64

2 39 24 30.01 female 2830 30.4 19.46

3 29 34 25.31 male 3580 45.61 36.28

4 39 25 31.88 female 3330 63.2 38.67

5 39 23 24.20 female 2960 27.96 51.35

6 39 32 36.29 male 3480 43.2 33.23

7 39 24 25.76 male 3680 36.94 42.62

8 39 27 28.54 male 3330 35.6 53.78

9 39 23 36.15 male 3740 45.34 -

Mean±SEM 38 26 29.60±1 3386.25±112 43.96±13 35.25±5

KCl

Figure 1. Cannulation of vessels and corresponding cotyledon. A and C) Chorionic plate (A) where

vessels are cannulated (C) (blue and orange arrow) B and D) Decidual surface (B) (maternal side) after

isolation of placental lobule and cotyledon perfusion (D). Orange arrows point to temperature sensor.

Turquiose arrow shows oxygen sensor E and F) temperature map of the maternal side of placenta in the

perfusion chamber just prior to (E) and after (F) perfusion. G) Doppler image of perfused placental

cotyledon in vitro, yellow arrow shows perfusate flowing through a vessel.

Time (seconds)

Baseline

A C

B D

E

F

G

B A